ACC CardiaCast

This episode of CardiaCast will feature a discussion on risk assessment and genetics in the prevention of cardiovascular disease.   This podcast is supported by Esperion, Merck, and Novartis.

This episode of CardiaCast will feature a discussion on risk assessment and the treatment of hypertriglyceridemia.   This podcast is supported by Esperion, Merck, and Novartis. 

In this final episode of the Increasing Role of UACR in Cardiovascular Care series, Drs. Ankeet Bhatt and Brendan Neuen will break down why UACR screening is one of the most powerful yet underused tools for identifying early cardiovascular risk. Together, they examine the latest evidence on therapies and lifestyle strategies that reduce albuminuria, discuss their impact on kidney and cardiovascular risk, and highlight practical considerations for integrating these approaches into everyday clinical care. This podcast is supported by a grant from Boehringer Ingelheim. Visit the course page to learn more about the role of UACR in Cardiovascular Care. 

The second episode of the Increasing Role of UACR in Cardiovascular Care series focuses on the most recent evidence-based guidelines for elevated UACR and related cardiovascular (CV) conditions. Dr. Ankeet Bhatt interviews Dr. Nihar Desai on key terminology for albuminuria and discuss CV conditions associated with UACR as a biomarker.   This podcast is supported by a grant from Boehringer Ingelheim. Visit the course page to learn more about the role of UACR in Cardiovascular Care. 

This episode of CardiaCast will feature a discussion on the treatment of atherosclerotic cardiovascular disease (ASCVD) risk – from lifestyle to advanced therapies, led by Dr. Maya Safarova. The conversation covers lifestyle "therapy", the treatment algorithm for primary and secondary prevention, and what's on the horizon for ASCVD.   This podcast is supported by Esperion, Merck, and Novartis.